This month, we cover the return of normal kickback and billing rules once the PHE ends on May 11, the current state of EKRA, and more.

We cover what’s next for COVID-19 tests, an automated HIV self-test for use in developing countries, and the latest breakthrough device designation numbers from the FDA.

This issue shares how to reduce liability risk for lab sales and marketing, two key recent cases for Labcorp, and six steps for a bloodborne pathogen exposure determination.

In our latest report, COVID-19 losses take a toll on Q4 2022 earnings for the lab industry—but it’s not all bad news—Amazon closes a key healthcare deal, and UnitedHealthcare expands coverage of genetic cancer tests.